Phase I study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII plus glioblastoma

被引：0
|
作者：
O'Rourke, Donald M.
Nasrallah, MacLean P.
Morrissette, Jennifer
Melenhorst, Jan J.
Lacey, Simon F.
Mansfield, Keith
Martinez-Lage, Maria
Desai, Arati
Brem, Steven
Maloney, Eileen
Mohan, Suyash
Wang, Sumei
Verma, Gaurav
Navenot, Jean-Marc
Shen, Angela
Zheng, Zhaohui
Levine, Bruce L.
Okada, Hideho
June, Carl H.
Maus, Marcela V.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-LB-083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-083
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Antigen-specific regulatory T cells redirected with chimeric receptor cure acute colitis
    Eshhar, Zelig
    Waks, Tova
    Elinav, Eran
    HUMAN GENE THERAPY, 2007, 18 (10) : 951 - 951
  • [42] A PHASE I STUDY OF EGFRVIII-DIRECTED CAR T CELLS COMBINED WITH PD-1 INHIBITION IN PATIENTS WITH NEWLY, DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA: TRIAL IN PROGRESS
    Bagley, Stephen
    Desai, Arati
    Binder, Zev
    Nasrallah, MacLean
    Hwang, Wei-Ting
    Maloney-Wilensky, Eileen
    Prior, Timothy
    Brem, Steven
    O'Rourke, Donald
    NEURO-ONCOLOGY, 2019, 21 : 221 - 221
  • [43] Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
    Brown, Christine E.
    Badie, Behnam
    Barish, Michael E.
    Weng, Lihong
    Ostberg, Julie R.
    Chang, Wen-Chung
    Naranjo, Araceli
    Starr, Renate
    Wagner, Jamie
    Wright, Christine
    Zhai, Yubo
    Bading, James R.
    Ressler, Julie A.
    Portnow, Jana
    D'Apuzzo, Massimo
    Forman, Stephen J.
    Jensen, Michael C.
    CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4062 - 4072
  • [44] Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma
    Choi, Bryan D.
    Suryadevara, Carter M.
    Gedeon, Patrick C.
    Herndon, James E., II
    Sanchez-Perez, Luis
    Bigner, Darell D.
    Sampson, John H.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (01) : 189 - 190
  • [45] A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
    O'Rourke, Donald M.
    Nasrallah, MacLean P.
    Desai, Arati
    Melenhorst, Jan J.
    Mansfield, Keith
    Morrissette, Jennifer J. D.
    Martinez-Lage, Maria
    Brem, Steven
    Maloney, Eileen
    Shen, Angela
    Isaacs, Randi
    Mohan, Suyash
    Plesa, Gabriela
    Lacey, Simon F.
    Navenot, Jean-Marc
    Zheng, Zhaohui
    Levine, Bruce L.
    Okada, Hideho
    June, Carl H.
    Brogdon, Jennifer L.
    Maus, Marcela V.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (399)
  • [46] Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells
    Chmielewski, Markus
    Hombach, Andreas A.
    Abken, Hinrich
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [47] Anti-EGFRvIII TandAbs recruiting either T or NK cells are highly specific and potent therapeutic antibody candidates for the treatment of EGFRvIII plus tumors
    Ellwanger, Kristina
    Reusch, Uwe
    Fucek, Ivica
    Weichel, Michael
    Gantke, Thorsten
    Knackmuss, Stefan
    Treder, Martin
    CANCER RESEARCH, 2016, 76
  • [48] A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
    Viapiano, Mariano
    Bhat, Krishna
    Abounader, Roger
    Wright, Karen
    Wick, Wolfgang
    Purow, Benjamin
    NEURO-ONCOLOGY, 2017, 19 (12) : 1574 - 1575
  • [49] A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA
    Wilson, Joseph
    Wilkinson, Daniel
    Ryan, Katherine
    Bigner, Darell
    Chambramohan, Vidya
    Fecci, Peter
    NEURO-ONCOLOGY, 2022, 24 : 228 - 229
  • [50] Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
    Hillary G. Caruso
    Ryuma Tanaka
    Jiyong Liang
    Xiaoyang Ling
    Aria Sabbagh
    Verlene K. Henry
    Tiara L. Collier
    Amy B. Heimberger
    Journal of Neuro-Oncology, 2019, 145 : 429 - 439
12345